7 DRUG INTERACTIONS
7.1 Clinically Significant Drug Interactions
Table 4 displays clinically significant drug interactions with Cisatracurium Besylate Injection.
|Drug or Drug Class||Clinical Implications*|
|Succinylcholine||The use of succinylcholine prior to Cisatracurium Besylate Injection administration may decrease the time to onset of maximum neuromuscular blockade but has no effect on the duration of neuromuscular blockade.|
|Inhalational Anesthetics||Administration of inhalational anesthetics with nitrous oxide/oxygen for greater than 30 minutes to achieve 1.25 Minimum Alveolar Concentration (MAC) may prolong the duration of action of initial and maintenance doses of Cisatracurium Besylate Injection. This may potentiate the neuromuscular blockade.|
|May prolong the neuromuscular blockade action of Cisatracurium Besylate Injection|
|Phenytoin, Carbamazepine||May increase resistance to the neuromuscular blockade action of Cisatracurium Besylate Injection resulting in shorter durations of neuromuscular blockade and infusion rate requirements may be higher.|